BRCA2 and ovarian carcinoma: On the other side, there were many other tumor markers identified, such as DNA ploidy of the primary tumor as an independent prognostic factor for operable breast cancer, circulating plasma DNA levels in breast cancer patients, genetic markers BRCA1 and BRCA2 for identifying individuals who are at risk of developing breast and ovarian cancers, and tissue markers [62].